Topic: pharmacy benefit management
Ohio’s attorney general is continuing his war on PBMs, this time by proposing a multi-step plan to improve transparency and lower drug costs.
Anthem reported a 9.2% increase in operating revenue in the first quarter of 2019 compared to the first quarter of 2018.
A look at the transparency controversy in Ohio, plus a look at other Medicaid news from around the country.
Two senators are asking the OIG to investigate pharmacy benefit managers' business practices, in particular controversial spread pricing models.
Azar said that any approach to bring down drug prices that does not tackle pharmacy benefit manager rebates “will not deliver the results.”
A House subcommittee held a hearing Wednesday on the rising costs of insulin with representatives from both the PBM and pharmaceutical industries.
Executives insist the pharmacy benefit management space is a competitive one, but industry watchers aren't so sure.
CareSource, Ohio's largest Medicaid insurer, will now contract with Express Scripts for PBM services, plus more payer headlines.
Pharmacy benefit managers warn that eliminating drug rebates puts little pressure on pharmaceutical companies to drive down costs.
Amid rising drug costs, employers and payers should be keeping a closer eye on products in the pipeline as they design formularies.